FureasuLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Tatsuya Sekine

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	1.6yrs
CEO ownership	0.5%
Management average tenure	no data
Board average tenure	5.8yrs

Recent management updates

Recent updates

CEO

Tatsuya Sekine (54 yo)

1.6yrs

Tenure

Mr. Tatsuya Sekine serves as President of fureasu Co.,Ltd since September 1, 2022 and also serves as its Director. He served as Senior Managing Director of Saint-Care Holding Corporation since April 2014 a...

Board Members

Name	Position	Tenure	Compensation	Ownership
Tatsuya Sekine	President & Representative Director	no data	no data	0.54% ¥ 11.4m
Taku Sawanobori	Representative Director	no data	no data	64.15% ¥ 1.3b
Masashi Akaike	Full-Time Auditor	6.8yrs	no data	0.21% ¥ 4.5m
Kasumi Nara	Audit & Supervisory Board Member	2.8yrs	no data	0.51% ¥ 10.7m
Daisuke Chiba	Independent Director	3.8yrs	no data	no data
Masataka Hiura	Auditor	6.8yrs	no data	no data
Nozomi Koga	Auditor	5.8yrs	no data	no data

5.8yrs

Average Tenure

54yo

Average Age

Experienced Board: 7062's board of directors are considered experienced (5.8 years average tenure).

FureasuLtd Management

Management criteria checks 1/4

Key information

Recent management updates

fureasu Co.,Ltd, Annual General Meeting, Jun 28, 2022

Recent updates

Upcoming dividend of JP¥10.57 per share

Fureasu Co.,Ltd. to Report Fiscal Year 2024 Results on May 14, 2024

Third quarter 2024 earnings released: EPS: JP¥13.18 (vs JP¥6.80 in 3Q 2023)

Fureasu Co.,Ltd. to Report Q3, 2024 Results on Feb 14, 2024

Second quarter 2024 earnings released: JP¥4.25 loss per share (vs JP¥9.35 loss in 2Q 2023)

Fureasu Co.,Ltd. to Report Q2, 2024 Results on Nov 14, 2023

First quarter 2024 earnings released: EPS: JP¥12.33 (vs JP¥0.85 loss in 1Q 2023)

Fureasu Co.,Ltd. to Report Q1, 2024 Results on Aug 14, 2023

Upcoming dividend of JP¥10.57 per share at 1.3% yield

Third quarter 2023 earnings released: EPS: JP¥6.80 (vs JP¥32.10 in 3Q 2022)

fureasu Co.,Ltd to Report Q3, 2023 Results on Feb 13, 2023

Second quarter 2023 earnings released: JP¥9.35 loss per share (vs JP¥17.12 profit in 2Q 2022)

fureasu Co.,Ltd to Report Q2, 2023 Results on Nov 14, 2022

First quarter 2023 earnings released: JP¥0.85 loss per share (vs JP¥21.86 profit in 1Q 2022)

fureasu Co.,Ltd to Report Q1, 2023 Results on Aug 15, 2022

fureasu Co.,Ltd, Annual General Meeting, Jun 28, 2022

fureasu Co.,Ltd to Report Fiscal Year 2022 Results on May 13, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

fureasu Co.,Ltd (TSE:7062) agreed to acquire Sky Heart Co., Ltd. from Yuko Yamada for ¥5 million.

New 90-day high: JP¥1,110

fureasu Co.,Ltd to Report Q3, 2021 Results on Feb 15, 2021

New 90-day high: JP¥959

fureasu Co.,Ltd to Report Q2, 2021 Results on Nov 13, 2020

fureasu Co.,Ltd (TSE:7062) acquired Hortensia Harmony Co, Ltd. from LEIS Health Care Co., Ltd for approximately ¥450 million.

fureasu Co.,Ltd to Report Q1, 2021 Results on Aug 05, 2020

CEO

Tenure

Board Members

Average Tenure

Average Age